Condition: Intensive Care Unit Syndrome · Intensive Care Neuropathy · Intensive Care (ICU) Myopathy · Sponsor: Barts & The London NHS Trust
To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.
This description comes directly from the study's public registry record.
Mark Griffiths, PhD FRCP · 07875999126 · Mark.griffiths@bartshealth.nhs.uk
Ashley Thomas, MSc · 07597875857 · ashleythomas@nhs.net
Always discuss trial participation with your own doctor first.
| St Bartholomew's hospital (Barts NHS trust) | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03753412